In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab ...
Clinical Trials Arena on MSN
ESMO26: Key data breathing new life into the lung cancer field
Clinical Trials Arena brings you the lung cancer highlights from ESMO 2026, with readouts from key players MSD, AstraZeneca, ...
Explore MIT Vishwashanti Gurukul World School in Pune, featured in Pune Mirror’s School Intelligence 2027 series for parents ...
Good morning, and welcome to the Bolt Biotherapeutics Conference Call and Webcast. Please note that this call is being recorded and will be available for replay on boltbio.com. [Operator Instructions] ...
A retrospective study of 37 patients suggests ultrasound-guided platelet-rich plasma injections for peripheral nerve injuries ...
InSilico Medicine Cayman TopCo announced preliminary promising first-in-human Phase I clinical trial data for ISM6331, an investigational oral pan-TEAD inhibitor designed using Chemistry42 generative ...
A case report describes a man with giant unresectable hepatocellular carcinoma whose inferior vena cava tumor thrombus ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the U.S. launch of ALASTIN Restorative Eye ...
Parklands College has partnered with Space Center Houston to bring the Space Exploration Educators Conference (SEEC) to Cape ...
TLR7/8 dual-agonist EIK1001 plus pembrolizumab and chemotherapy in first-line, stage 4 non-small cell lung cancer (NSCLC) demonstrates durable effect in combination with standard-of-care, and a ...
Sacituzumab tirumotecan improved survival vs chemotherapy in patients with advanced or recurrent endometrial cancer after platinum and immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results